The Novella Clinical Story – Abridged.

In 2013 Novella Clinical was acquired by Quintiles to exclusively serve two distinct customer groups: small and mid-sized oncology companies, and medical device and diagnostic companies. As a distinct business unit within Quintiles’ Clinical Development Group, Novella continues to excel in providing the highest level of customer service, operational excellence, and flexibility our customers require. The year 2013 also marks our 15th anniversary; highlights of our journey follow.

  • 1998: Clinical research professionals founded what was formerly known as PharmaLink with a single vision: use advances in internet-based technology and security to simplify and revolutionize the clinical trial process.
  • 1999: Through an infusion of capital and an affiliation with Family Health International, PharmaLink (thereafter PharmaLinkFHI) realized its ambitious goal to become a global, full-service CRO.
  • 2000: We became the first CRO to license Oracle's InForm™ software.
  • 2004: We attained ISO 9001:2008 certification, one of the first and only CROs to achieve this honor.
  • 2005:
    • The Medical Device & Diagnostics division was formally launched;
    • We licensed Medidata’s RAVE™ software;
    • Our clinical staffing group was created to support sponsors and service providers strategic resourcing and clinical solutions globally.
  • 2008: The acquisition of Matrix Clinical is finalized, formalizing our European headquarters.
  • 2009: We rebranded as Novella Clinical.
  • 2010: Our oncology division expanded with the acquisitions of Prologue Clinical Research and research staff from OSI Pharmaceuticals.
  • 2013: Novella Clinical is acquired by Quintiles as a distinct business unit.

Certified QualityCertified Quality

We don't just say quality... we prove it.